191,600.00
-600(-0.31%)
Currency In KRW
Address
16 Daewangpangyo-Ro 712 Beon-Gil
Seongnam, 13488
Korea, Republic of
Phone
82 31 8018 9800
Website
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Employees
102
First IPO Date
December 19, 2018
| Name | Title | Pay | Year Born |
| Sang Hoon Lee | Founder, President & Chief Executive Officer | 0 | N/A |
| Hakju Kwon | Senior Vice President, Head of Neuroscience & NCD | 0 | N/A |
| Jong Hwa Won | Executive Vice President, Chief Translational Research Officer & Head of Early Development | 0 | N/A |
| Sung Ju Moon | Executive VP & Chief ADC Development Officer | 0 | N/A |
| You Weon-Kyoo | Executive VP, Chief Scientific Officer & Head of R&D | 0 | N/A |
| Jaecheon Lee | Executive VP, MD & CFO | 0 | N/A |
| Jung Dae Kim | Executive VP & COO | 0 | N/A |
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. The company is headquartered in Seongnam, South Korea.